MULTIPLE SUB-SETS OF CD4(+) AND CD8(+) CYTOTOXIC T-CELL CLONES DIRECTED TO AUTOLOGOUS HUMAN-MELANOMA IDENTIFIED BY CYTOKINES PROFILES

被引:29
作者
MACCALLI, C [1 ]
MORTARINI, R [1 ]
PARMIANI, G [1 ]
ANICHINI, A [1 ]
机构
[1] IST NAZL TUMORI, DIV EXPTL ONCOL D, I-20133 MILAN, ITALY
关键词
D O I
10.1002/ijc.2910570111
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
CD4(+) and CD8(+) cytotoxic T-cell (CTL) clones, selected for T-cell-receptor (TcR)-dependent lysis of the autologous tumor and isolated from peripheral-blood lymphocytes (PBL) or tumor-infiltrating lymphocytes (TIL) of 3 melanoma patients, were characterized for the pattern of 13 different cytokines release by antibody- or tumor-mediated triggering. Induction or enhancement of cytokine release by anti-CD3 monoclonal antibody (MAb) led to the identification of 2 major sub-sets of CD8(+) CTL clones on the basis of production of IL-4. Within the 2 groups of IL-4-producing or non-producing clones, further sub-sets could be identified on the basis of differential production of IL-1 beta, IL-2, IL-6, IL-8, IL-10, TNF-alpha, TNF beta and IFN-gamma. A similar analysis performed on a panel of CD4(+) CTL clones indicated multiple patterns consistent with at least 4 major sub-sets, but further complexity was evident in each sub-set on the basis of differential production of IL-1, IL2, IL-6, IL-10 and G-CSF. The cytokine profile of CD4(+) and CD8(+) clones, as determined after anti-CD3 stimulation, was different from the pattern seen after co-culture with autologous tumor, since many clones released cytokines such as IL-4, IL-10, IFN-alpha and -gamma, TNF-alpha and GM-CSF after activation with only 1 of the 2 stimuli. These results indicate that CD4(+) and CD8(+) CTL clones reacting to human melanoma belong to a highly complex repertoire of functional subsets characterized by distinct cytokine profiles. In addition, the cytokine pattern of each T-cell sub-set can be modulated by changing the activation signals delivered to the T cell. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:56 / 62
页数:7
相关论文
共 21 条
[1]   MELANOMA-CELLS AND NORMAL MELANOCYTES SHARE ANTIGENS RECOGNIZED BY HLA-A2-RESTRICTED CYTOTOXIC T-CELL CLONES FROM MELANOMA PATIENTS [J].
ANICHINI, A ;
MACCALLI, C ;
MORTARINI, R ;
SALVI, S ;
MAZZOCCHI, A ;
SQUARCINA, P ;
HERLYN, M ;
PARMIANI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (04) :989-998
[2]   EXPRESSION OF CYTOKINE GENES, INCLUDING IL-6, IN HUMAN-MALIGNANT MELANOMA CELL-LINES [J].
COLOMBO, MP ;
MACCALLI, C ;
MATTEI, S ;
MELANI, C ;
RADRIZZANI, M ;
PARMIANI, G .
MELANOMA RESEARCH, 1992, 2 (03) :181-189
[3]  
DELPRETE G, 1993, J IMMUNOL, V150, P353
[4]  
DELPRETE G, 1988, J IMMUNOL, V140, P4193
[5]   PURIFIED PROTEIN DERIVATIVE OF MYCOBACTERIUM-TUBERCULOSIS AND EXCRETORY-SECRETORY ANTIGEN(S) OF TOXOCARA-CANIS EXPAND INVITRO HUMAN T-CELLS WITH STABLE AND OPPOSITE (TYPE-1 T-HELPER OR TYPE-2 T-HELPER) PROFILE OF CYTOKINE PRODUCTION [J].
DELPRETE, GF ;
DECARLI, M ;
MASTROMAURO, C ;
BIAGIOTTI, R ;
MACCHIA, D ;
FALAGIANI, P ;
RICCI, M ;
ROMAGNANI, S .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (01) :346-350
[6]   HELPER ACTIVITY FOR IMMUNOGLOBULIN-SYNTHESIS OF T-HELPER TYPE-1 (TH1) AND TH2 HUMAN T-CELL CLONES - THE HELP OF TH1 CLONES IS LIMITED BY THEIR CYTOLYTIC CAPACITY [J].
DELPRETE, GF ;
DECARLI, M ;
RICCI, M ;
ROMAGNANI, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (04) :809-813
[7]  
ENK AH, 1993, J IMMUNOL, V151, P2390
[8]   DIFFERENTIAL EFFECT OF TRANSFORMING GROWTH-FACTOR-BETA ON THE SYNTHESIS OF T(H)1-LYMPHOKINES AND T(H)2-LIKE LYMPHOKINES BY HUMAN LYMPHOCYTES-T [J].
FARGEAS, C ;
WU, CY ;
NAKAJIMA, T ;
COX, D ;
NUTMAN, T ;
DELESPESSE, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (08) :2173-2176
[9]   SPECIFIC RELEASE OF CYTOKINES BY LYMPHOCYTES INFILTRATING HUMAN MELANOMAS IN RESPONSE TO SHARED MELANOMA ANTIGENS [J].
HOM, SS ;
SCHWARTZENTRUBER, DJ ;
ROSENBERG, SA ;
TOPALIAN, SL .
JOURNAL OF IMMUNOTHERAPY, 1993, 13 (01) :18-30
[10]   SPECIFIC IMMUNE RECOGNITION OF AUTOLOGOUS TUMOR BY LYMPHOCYTES INFILTRATING COLON CARCINOMAS - ANALYSIS BY CYTOKINE SECRETION [J].
HOM, SS ;
ROSENBERG, SA ;
TOPALIAN, SL .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1993, 36 (01) :1-8